Non-ischemic left ventricular dysfunction after pediatric cardiac transplantation: Treatment with plasmapheresis and OKT3

Journal of Heart and Lung Transplantation

Volumn 23, Issue 5, 2004, Pages 552-557

  McOmber, Delwyn ^a,d   Ibrahim, Jill ^a   Lublin, Douglas M ^b   Saffitz, Jeffrey E ^b   Ong Simon, Catherine ^c   Mendeloff, Eric N ^a   Huddleston, Charles B ^a   Canter, Charles E ^a  

^a WASHINGTON UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^d ST LOUIS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; OKT 3; STEROID;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HUMAN; INFANT; INOTROPISM; MALE; PEDIATRIC SURGERY; PLASMAPHERESIS; PRIORITY JOURNAL; SURVIVAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CHILD; CYCLOPHOSPHAMIDE; FEMALE; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; MALE; MUROMONAB-CD3; PLASMAPHERESIS; POSTOPERATIVE COMPLICATIONS; STEROIDS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 2342454316     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(03)00308-5     Document Type: Article

References (26)

1. Hammond E.H., Yowell R.L., Nunoda S., et al. Vascular (humoral) rejection in heart transplantation Pathologic observations and clinical implications. J Heart Transplant. 8:1989;430-443
2. Mills R.M., Naftel D.C., Kirklin J.K., et al. Heart transplant rejection with hemodynamic compromise A multiinstitutional study of the role of endomyocardial cellular infiltrate. J Heart Lung Transplant. 16:1997;813-821
3. Pahl E., Naftel D.C., Canter C.E., et al. Death after rejection with severe hemodynamic compromise in pediatric heart transplant recipients A multi-institutional study. J Heart Lung Transplant. 20:2001;279-287
4. McNamara D., Di Salvo T., Mathier M., et al. Left ventricular dysfunction after heart transplantation Incidence and role of enhanced immunosuppression. J Heart Lung Transplant. 15:1996;506-515
5. Malafa M., Mancini M.C., Myles J.L., et al. Successful tratment of acute humoral rejection in a heart transplant patients. J Heart Lung Transplant. 11:1992;486-491
6. Berglin E., Kjellstrom C., Mantovani V., et al. Plasmapharesis as a rescue therapy to resolve cardiac rejection with vasculitis and severe heart failure. A report of 5 cases. Transplant Int. 8:1995;882-887
7. Miller L.W., Wesp A., Jennison S.H., et al. Vascular rejection in heart transplant recipients. J Heart Lung Transplant. 12:(suppl):1993;S147-152
8. Billingham M.E., Cary N.R.B., Hammond M.E., et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection Heart rejection study group. J Heart Lung Transplant. 9:1990;587-593
9. Bonnaud E.N., Lewis N.P., Masek M.A., et al. Reliability and usefulness of immunofluorescence in heart transplantation. J Heart Lung Transplant. 14:1995;163-171
10. Kobashigawa J.A., Moriguchi J.D., Laks H., et al. Successful therapy for cardiac transplant recipients with hemodynamic compromising rejection. Circulation. 94:1996;1-479
11. Olsen S.L., Wagoner L.E., Hammond E.H., et al. Vascular rejection in heart transplantation Clinical correlation, treatment options, and future considerations. J Heart Lung Transplant. 12:(suppl):1993;S135-142
12. Crespo M., Pascual M., Tolkoff-Rubin N., et al. Acute humoral rejection in renal allograft recipients I. Incidence, serology and clinical characteristics. Transplantation. 71:2001;652-658
13. Montgomery R.A., Zachary A.A., Rascuen L.C., et al. Plasmapharesis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients. Transplantation. 70:2000;887-895
14. Michaels P.J., Espejo M.L., Kobashigawa J., et al. Humoral rejection in cardiac transplantation Risk factors, hemodynamic consequences and relationship to transplant coronary artery disease. J Heart Lung Transplant. 22:2003;58-69
15. Grauhan O., Knosalla C., Ewert R., et al. Plasmapharesis and cyclophosphamide in the treatment of humoral rejection after heart transplantation. J Heart Lung Transplant. 20:2001;316-321
16. Pahl E., Crawford S.E., Cohn R.A., et al. Reversal of severe late left ventricular failure after pediatric heart transplantation and possible role of plasmapheresis. Am J Cardiol. 85:2000;735-739
17. Hammond E.H., Yowell R.L., Nunoda S., et al. Menlove (humoral) rejection in heart transplantation Pathologic observations and clinical implications. J Heart Transplant. 8:1989;430-443
18. Rodriguez E.R. The pathology of heart transplant biopsy specimens Revisiting the 1990 ISHLT working formulations. J Heart Lung Transplant. 22:2003;3-15
19. Nakae H., Asanuma Y., Tajami K. Cytokine removal by plasma exchange with continuous hemodiafiltration in critically ill patients. Ther Apheresis. 6:2002;419-424
20. Reeves J.H. A review of plasma exchange in sepsis. Blood Purif. 20:2002;282-288
21. Heitmiller R.F. Myasthenia gravis Clinical features, pathogenesis, evluation, and medical management. Sem Thorac Cardiovasc Surg. 11:1999;41-46
22. Garrett H.E. Jr, Groshart K., Dvall-Seaman D., et al. Treatment of humoral rejection with rituximab. Ann Thorac Surg. 74:2002;1240-1242
23. Arnanda J.M. Jr, Scornik J.C., Normann S.J., et al. Anti-CD20 monoclonal antibody (rituximab) therapy for acute cardiac humoral rejection A case report. Transplantation. 73:2002;907-910
24. Mehra M.R., Uber P.A., Uber W.E., et al. Allosensitization in heart transplantation Implications and management strategies. Curr Opin Cardiol. 18:2003;153-158
25. Lehrer M.S., Rook A.H., Tomaszewski J.E., et al. Successful reversal of severe refractory cardiac rejection by photopharesis. J Heart Lung Transplant. 20:2001;1233-1236
26. Kirklin J.K., George J.F., McGiffin D.C., et al. Total lymphoid irradiation Is there a role in pediatric heart transplantation? J Heart Lung Transplant. 12:(suppl):1993;S293-300